MariMed Inc. (MRMD) income statement
MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.06−0.00 (-3.39%)
Close on Oct 19, 2026Market cap $22.97MP/E –Yield –
MariMed Inc. financial ratios
See a number that looks wrong?
Close on Oct 19, 2026Market cap $22.97MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||||||||
| Gross margin | 36.2% | 39.7% | 44.4% | 47.7% | 54.6% | 61.5% | 41.0% | 65.9% | 63.9% | 54.6% | -23.4% | -115.2% | -2,807.6% | -2,441.1% | – |
| Operating margin | -1.8% | 1.7% | 9.7% | 15.2% | 22.1% | 28.6% | -91.1% | -45.2% | 2.1% | 21.8% | -133.1% | -924.8% | -61,741.7% | -98,699.0% | – |
| EBITDA margin | 3.3% | 6.7% | 13.4% | 17.8% | – | 32.1% | -88.9% | -39.6% | 8.1% | 29.2% | – | – | – | – | – |
| Pre-tax margin | -6.8% | -2.7% | -4.4% | 14.6% | 19.6% | 8.8% | -179.4% | – | – | – | – | – | – | – | – |
| Net profit margin | -9.1% | -7.9% | -10.8% | 10.0% | 5.9% | 4.2% | -178.0% | -114.8% | -19.7% | -5.6% | -145.4% | -8,396.6% | -59,248.6% | -103,126.1% | – |
| Free cash flow margin | 4.1% | -3.3% | -8.2% | -3.6% | 14.8% | -2.6% | -74.1% | -99.8% | -316.6% | -99.9% | – | -512.0% | – | – | – |
| Effective tax rate | – | – | – | 30.2% | 68.0% | 46.0% | – | – | – | – | – | – | – | – | – |
| Returns on capital | |||||||||||||||
| Return on equity | -26.7% | -19.6% | -25.4% | 28.8% | 32.5% | 29.7% | -238.5% | -37.4% | -22.8% | 16.0% | 95.7% | 504.7% | 70.2% | 240.8% | – |
| Return on assets | -7.1% | -6.2% | -9.2% | 9.8% | 7.2% | 3.1% | -112.3% | -23.6% | -5.9% | -3.2% | -68.8% | -449.1% | -60.4% | -519.1% | – |
| Return on tangible assets | -8.9% | -7.5% | -11.0% | 11.7% | 7.4% | 3.3% | -116.1% | -23.7% | -6.0% | -3.2% | -68.8% | -449.1% | -60.4% | -519.1% | – |
| Return on invested capital | – | – | – | 29.3% | 56.5% | 37.7% | -120.4% | – | – | – | – | – | – | – | – |
| Return on capital employed | -1.9% | 1.6% | 9.9% | 18.4% | 36.0% | 37.2% | -84.9% | -11.9% | 1.3% | 304.8% | 186.8% | -671.0% | 284.8% | 230.4% | – |
| Return on total capital | – | – | – | 29.8% | 74.3% | 60.3% | -141.1% | – | – | – | – | – | – | – | – |
| NOPAT | -$2.23M | $2.06M | $11.36M | $14.21M | $10.75M | $7.85M | -$32.81M | -$4.23M | $100.84K | $612.49K | -$1.34M | -$645.70K | -$440.93K | -$612.08K | – |
| Cash flow quality | |||||||||||||||
| OCF / Sales | 4.8% | 4.3% | 5.3% | 5.5% | 29.5% | 6.6% | -52.9% | -24.5% | 29.1% | -5.6% | -30.9% | -515.1% | -1,178.4% | -16,237.6% | – |
| OCF / Net income | -0.53 | -0.54 | -0.49 | 0.54 | 4.96 | 1.58 | 0.30 | 0.21 | -1.48 | 1.00 | 0.21 | 0.06 | 0.02 | 0.16 | – |
| FCF / OCF | 84.8% | -76.3% | -154.5% | -66.1% | 50.1% | -38.7% | 140.1% | 406.9% | -1,088.5% | 1,799.6% | – | 99.4% | – | – | – |
| FCF / Net income | -0.45 | 0.42 | 0.76 | -0.36 | 2.49 | -0.61 | 0.42 | 0.87 | 16.09 | 17.91 | – | 0.06 | – | – | – |
| FCF / EBITDA | 123.4% | -49.2% | -61.3% | -20.3% | – | -8.0% | 83.4% | 251.9% | -3,915.4% | -342.2% | – | – | – | – | – |
| Unlevered free cash flow | $12.45M | $310.76K | -$4.96M | -$3.49M | $19.84M | $6.44M | -$23.76M | -$8.38M | -$18.74M | -$3.79M | – | -$502.29K | – | – | – |
| Levered free cash flow | $6.53M | -$5.18M | -$12.22M | -$4.83M | $17.98M | -$1.31M | -$33.81M | -$11.83M | -$19.21M | -$3.56M | – | -$452.56K | – | – | – |
| Efficiency | |||||||||||||||
| Asset turnover | 0.78 | 0.78 | 0.85 | 0.97 | 1.22 | 0.74 | 0.63 | 0.21 | 0.30 | 0.58 | 0.47 | 0.05 | 0.00 | 0.01 | – |
| Fixed asset turnover | 1.74 | 1.72 | 1.85 | 2.00 | 2.25 | 1.15 | 1.19 | 0.39 | 0.39 | 1.32 | 29.26 | 33.15 | – | – | – |
| Receivables turnover | 17.90 | 19.79 | 26.17 | 46.03 | 29.12 | 12.20 | 12.94 | 3.47 | 6.11 | 9.83 | 10.48 | 1.76 | 0.02 | – | – |
| Days sales outstanding | 20.4 | 18.4 | 13.9 | 7.9 | 12.5 | 29.9 | 28.2 | 105.2 | 59.7 | 37.1 | 34.8 | 206.8 | 20,219.5 | – | – |
| Payables turnover | 7.34 | 8.57 | 10.58 | 11.95 | 10.88 | 4.01 | 6.23 | 1.20 | 1.33 | 3.02 | 3.18 | 0.26 | 0.05 | 0.23 | – |
| Days payables outstanding | 49.7 | 42.6 | 34.5 | 30.5 | 33.5 | 91.1 | 58.6 | 304.7 | 275.0 | 120.9 | 114.9 | 1,405.1 | 8,084.9 | 1,607.2 | – |
| Inventory turnover | 2.91 | 3.23 | 3.69 | 4.79 | 6.65 | 4.86 | 41.08 | 44.67 | – | – | – | – | – | – | – |
| Days inventory outstanding | 125.5 | 112.8 | 98.9 | 76.2 | 54.9 | 75.1 | 8.9 | 8.2 | – | – | – | – | – | – | – |
| Operating cycle | 145.9 | 131.3 | 112.8 | 84.1 | 67.4 | 105.0 | 37.1 | 113.3 | – | – | – | – | – | – | – |
| Cash conversion cycle | 96.1 | 88.7 | 78.3 | 53.6 | 33.9 | 13.9 | -21.5 | -191.4 | – | – | – | – | – | – | – |
| CapEx to revenue | 0.73% | 7.6% | 13.5% | 9.1% | 14.7% | 9.2% | 21.2% | 75.3% | 345.7% | 94.4% | – | 3.0% | – | – | – |
| CapEx to OCF | 15.2% | 176.3% | 254.5% | 166.1% | 49.9% | 138.7% | -40.1% | -306.9% | 1,188.5% | -1,699.6% | – | -0.59% | – | – | – |
| CapEx to depreciation | 0.14 | 1.51 | 3.63 | 3.54 | – | 2.60 | 9.67 | 13.56 | 57.78 | 12.66 | – | – | – | – | – |
| Liquidity | |||||||||||||||
| Current ratio | 1.00 | 1.07 | 1.67 | 1.67 | 1.64 | 0.91 | 0.20 | 1.58 | 0.32 | 0.40 | 0.17 | 0.85 | 0.72 | 0.19 | 0.54 |
| Quick ratio | 0.38 | 0.40 | 0.85 | 0.93 | 1.28 | 0.61 | 0.17 | 1.57 | 0.32 | 0.40 | 0.17 | 0.85 | 0.72 | 0.19 | 0.54 |
| Cash ratio | 0.15 | 0.15 | 0.48 | 0.37 | 1.10 | 0.19 | 0.06 | 0.41 | 0.08 | 0.09 | 0.03 | 0.65 | 0.01 | 0.01 | 0.34 |
| Working capital | $223.00K | $3.50M | $20.57M | $17.66M | $17.39M | -$2.18M | -$29.34M | $5.76M | -$10.45M | -$3.68M | -$4.70M | -$234.19K | -$428.59K | -$513.76K | -$158.68K |
| Net current asset value | -$78.54M | -$75.93M | -$55.78M | -$13.02M | -$4.57M | -$32.58M | -$47.87M | -$5.49M | -$16.23M | -$6.68M | -$4.70M | -$2.28M | -$2.48M | -$513.76K | -$158.68K |
| Leverage | |||||||||||||||
| Total debt | – | – | – | $25.94M | $17.26M | $10.68M | $23.10M | – | – | – | – | – | – | – | – |
| Net debt | – | – | – | $16.08M | -$12.67M | $6.33M | $20.91M | – | – | – | – | – | – | – | – |
| Debt / Equity | – | – | – | 0.45 | 0.48 | 1.32 | 3.65 | – | – | – | – | – | – | – | – |
| Debt ratio | – | – | – | 17.0% | 14.0% | 14.0% | 37.5% | – | – | – | – | – | – | – | – |
| Assets to equity | 4.05 | 3.54 | 2.85 | 2.66 | 3.39 | 9.44 | 9.73 | 1.34 | 2.93 | -15.53 | -1.92 | -0.86 | -1.63 | -0.24 | -1.20 |
| Long-term debt to assets | – | – | – | 17.0% | 14.0% | 14.0% | – | – | – | – | – | – | – | – | – |
| Long-term debt to equity | – | – | – | 0.45 | 0.48 | 1.32 | – | – | – | – | – | – | – | – | – |
| Total debt / Capitalization | – | – | – | 31.2% | 32.2% | 56.9% | 78.5% | – | – | – | – | – | – | – | – |
| Long-term debt / Capitalization | – | – | – | 31.2% | 32.2% | 56.9% | – | – | – | – | – | – | – | – | – |
| Net debt / EBITDA | – | – | – | 0.68 | – | 0.39 | -0.52 | – | – | – | – | – | – | – | – |
| Total debt / EBITDA | – | – | – | 1.09 | – | 0.65 | -0.57 | – | – | – | – | – | – | – | – |
| Cash flow to debt | – | – | – | 28.2% | 207.7% | 31.6% | -104.5% | – | – | – | – | – | – | – | – |
| Goodwill / Assets | 11.8% | 7.6% | 6.1% | 5.3% | 1.7% | 2.7% | – | – | – | – | – | – | – | – | – |
| Intangibles to total assets | 20.3% | 16.6% | 14.8% | 14.6% | 1.8% | 5.6% | 3.8% | 0.22% | 1.0% | – | – | – | – | – | – |
| Interest coverage | |||||||||||||||
| EBIT / Interest expense | -0.38 | 0.38 | 1.57 | 12.03 | 11.40 | 1.48 | -3.27 | -1.23 | 0.22 | 2.67 | -8.18 | -14.54 | – | – | – |
| EBITDA / Interest expense | 0.71 | 1.51 | 2.17 | 14.06 | – | 1.66 | -3.19 | -1.08 | 0.83 | 3.58 | – | – | – | – | – |
| (EBITDA − CapEx) / Interest expense | 0.55 | -0.21 | -0.02 | 6.89 | – | 1.19 | -3.95 | -3.12 | -34.58 | -7.99 | – | – | – | – | – |
| Per share | |||||||||||||||
| Revenue per share | 0.40 | 0.41 | 0.40 | 0.39 | 0.36 | 0.16 | 0.20 | 0.06 | 0.03 | 0.06 | 0.04 | 0.0028 | 0.0000 | 0.0000 | – |
| EPS (basic) | -0.04 | -0.03 | -0.04 | 0.04 | 0.02 | 0.01 | -0.39 | -0.07 | -0.01 | -0.0040 | -0.04 | -0.23 | -0.02 | -0.04 | – |
| EPS (diluted) | -0.04 | -0.03 | -0.04 | 0.04 | 0.02 | 0.01 | -0.39 | -0.07 | -0.01 | -0.0040 | -0.04 | -0.23 | -0.02 | -0.04 | – |
| Book value per share | 0.13 | 0.15 | 0.18 | 0.17 | 0.11 | 0.03 | 0.03 | 0.29 | 0.06 | -0.0086 | -0.06 | -0.06 | -0.03 | -0.02 | – |
| Tangible book value per share | 0.02 | 0.06 | 0.11 | 0.10 | 0.10 | 0.01 | 0.02 | 0.29 | 0.06 | -0.0086 | -0.06 | -0.06 | -0.03 | -0.02 | – |
| Cash per share | 0.02 | 0.02 | 0.04 | 0.03 | 0.09 | 0.01 | 0.0096 | 0.02 | 0.0073 | 0.0089 | 0.0050 | 0.03 | 0.0003 | 0.0003 | – |
| Operating cash flow per share | 0.02 | 0.02 | 0.02 | 0.02 | 0.11 | 0.01 | -0.11 | -0.01 | 0.0100 | -0.0031 | -0.01 | -0.01 | -0.0003 | -0.0050 | – |
| Free cash flow per share | 0.02 | -0.01 | -0.03 | -0.01 | 0.05 | -0.0042 | -0.15 | -0.06 | -0.11 | -0.06 | – | -0.01 | – | – | – |
| CapEx per share | 0.0029 | 0.03 | 0.05 | 0.04 | 0.05 | 0.01 | 0.04 | 0.04 | 0.12 | 0.05 | – | 0.0001 | – | – | – |
| Valuation at period end | |||||||||||||||
| Market cap | $37.06M | $44.12M | $103.36M | $120.78M | $286.79M | $136.17M | $134.86M | $660.14M | $114.60M | $15.06M | $4.82M | $3.20M | $2.03M | – | – |
| Enterprise value | $28.64M | $32.59M | $88.29M | $107.91M | $260.15M | $152.47M | $135.57M | $654.01M | $117.93M | $15.11M | $4.11M | -$1.58M | $2.02M | – | – |
| P/E | – | – | – | 9.0x | 39.7x | 63.5x | – | – | – | – | – | – | – | – | – |
| P/S | 0.2x | 0.3x | 0.7x | 0.9x | 2.4x | 2.7x | 3.0x | 55.7x | 18.9x | 4.2x | 3.8x | 36.2x | 2,249x | – | – |
| P/B | 0.7x | 0.8x | 1.5x | 2.1x | 7.9x | 16.8x | 21.3x | 10.7x | 10.4x | -27.3x | -2.5x | -1.7x | -2.0x | – | – |
| P/TBV | 4.2x | 1.8x | 2.6x | 3.4x | 8.4x | 35.8x | 34.0x | 10.7x | 10.7x | -27.3x | -2.5x | -1.7x | -2.0x | – | – |
| P/Gross profit | 0.6x | 0.7x | 1.6x | 1.9x | 4.3x | 4.3x | 7.2x | 84.5x | 29.6x | 7.7x | -16.2x | -31.4x | -80.1x | – | – |
| P/OCF | 4.8x | 6.5x | 13.1x | 16.5x | 8.0x | 40.3x | -5.6x | -227x | 64.9x | -76.1x | -12.3x | -7.0x | -191x | – | – |
| P/FCF | 5.7x | – | – | – | 15.9x | – | – | – | – | – | – | – | – | – | – |
| EV/Sales | 0.2x | 0.2x | 0.6x | 0.8x | 2.1x | 3.0x | 3.0x | 55.2x | 19.4x | 4.2x | 3.2x | -17.8x | 2,239x | – | – |
| EV/Gross profit | 0.5x | 0.5x | 1.3x | 1.7x | 3.9x | 4.9x | 7.2x | 83.7x | 30.4x | 7.8x | -13.9x | 15.5x | -79.8x | – | – |
| EV/EBITDA | 5.4x | 3.1x | 4.4x | 4.5x | – | 9.3x | – | – | 240x | 14.5x | – | – | – | – | – |
| EV/EBIT | – | 12.5x | 6.1x | 5.3x | 9.7x | 10.5x | – | – | 924x | 19.5x | – | 1.9x | – | – | – |
| EV/OCF | 3.7x | 4.8x | 11.2x | 14.8x | 7.3x | 45.1x | -5.6x | -225x | 66.8x | -76.4x | -10.5x | 3.5x | -190x | – | – |
| EV/FCF | 4.4x | – | – | – | 14.5x | – | – | – | – | – | – | 3.5x | – | – | – |
| Earnings yield | -39.1% | -28.3% | -15.5% | 11.2% | 2.5% | 1.6% | -60.2% | -2.1% | -1.0% | -1.3% | -38.3% | -232.2% | -26.3% | – | – |
| FCF yield | 17.6% | -11.7% | -11.8% | -4.0% | 6.3% | -0.96% | -25.1% | -1.8% | -16.8% | -23.7% | – | -14.2% | – | – | – |
| Cost structure | |||||||||||||||
| R&D to revenue | – | – | – | – | – | – | – | – | – | – | 7.3% | – | – | – | – |
| SG&A to revenue | – | – | – | – | – | – | – | – | – | 21.6% | 44.7% | 342.0% | 13,501.7% | 23,494.3% | – |
| Stock-based comp to revenue | 1.2% | 0.67% | 0.69% | 4.7% | – | – | – | 48.6% | 17.8% | 4.6% | 3.6% | 40.7% | 10,398.2% | 20,891.7% | – |
| Per employee | |||||||||||||||
| Total employees | 923 | 832 | 721 | 681 | 326 | 233 | 97 | 28 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Revenue per employee | $173.16K | $189.55K | $206.10K | $196.78K | $372.59K | $218.43K | $470.15K | $423.28K | $1.52M | $891.03K | $317.54K | $22.10K | $226 | $196 | – |
| Gross profit per employee | $62.71K | $75.26K | $91.43K | $93.92K | $203.26K | $134.44K | $192.80K | $278.96K | $968.76K | $486.66K | -$74.16K | -$25.45K | -$6.35K | -$4.79K | – |
| Operating profit per employee | -$3.06K | $3.14K | $19.95K | $29.91K | $82.40K | $62.36K | -$428.15K | -$191.29K | $31.91K | $193.83K | -$422.64K | -$204.34K | -$139.54K | -$193.70K | – |
| Net income per employee | -$15.69K | -$14.98K | -$22.23K | $19.78K | $22.16K | $9.20K | -$836.96K | -$485.86K | -$298.52K | -$49.71K | -$461.73K | -$1.86M | -$133.90K | -$202.39K | – |
| Free cash flow per employee | $7.07K | -$6.22K | -$16.95K | -$7.09K | $55.16K | -$5.61K | -$348.52K | -$422.58K | -$4.80M | -$890.50K | – | -$113.14K | – | – | – |
| Growth | |||||||||||||||
| Revenue 1Y growth | 1.3% | 6.1% | 10.9% | 10.3% | 138.7% | 11.6% | 284.8% | 95.3% | 70.2% | 180.6% | 1,337.1% | 9,677.0% | 15.2% | – | – |
| Revenue 3Y CAGR | 6.0% | 9.1% | 42.9% | 43.2% | 117.2% | 103.2% | 133.9% | 110.5% | 309.5% | 1,479.8% | 1,074.0% | – | – | – | – |
| Revenue 5Y CAGR | 25.7% | 28.2% | 65.8% | 85.7% | 102.5% | 109.2% | 248.8% | 566.1% | 499.3% | – | – | – | – | – | – |
| Revenue 10Y CAGR | 62.2% | 111.4% | 232.3% | 233.6% | – | – | – | – | – | – | – | – | – | – | – |
| Gross profit 1Y growth | -7.6% | -5.0% | 3.1% | -3.5% | 111.5% | 67.5% | 139.4% | 101.6% | 99.1% | 756.2% | -191.5% | -301.0% | -32.4% | – | – |
| Gross profit 3Y CAGR | -3.3% | -1.9% | 28.1% | 50.7% | 104.0% | 100.7% | 112.6% | – | – | – | – | – | – | – | – |
| Gross profit 5Y CAGR | 13.1% | 27.3% | 53.2% | 75.2% | 102.5% | – | – | – | – | – | – | – | – | – | – |
| EBIT 1Y growth | -208.1% | -81.9% | -29.4% | -24.2% | 84.9% | 135.0% | -675.4% | -4,295.9% | -83.5% | 145.9% | -106.8% | -46.4% | 28.0% | – | – |
| EBIT 3Y CAGR | – | -54.0% | -0.34% | – | – | 384.6% | – | – | – | – | – | – | – | – | – |
| EBIT 5Y CAGR | – | – | – | 175.8% | 103.2% | – | – | – | – | – | – | – | – | – | – |
| EBITDA 1Y growth | -49.7% | -47.2% | -16.2% | – | – | 140.3% | -762.7% | -1,057.5% | -52.9% | – | – | – | – | – | – |
| EBITDA 3Y CAGR | -39.4% | – | 6.9% | – | – | 221.7% | – | – | – | – | – | – | – | – | – |
| EBITDA 5Y CAGR | -20.2% | – | – | 117.4% | – | – | – | – | – | – | – | – | – | – | – |
| Net income 1Y growth | -16.2% | 22.2% | -219.0% | 86.4% | 237.0% | 102.6% | -496.8% | -1,039.3% | -500.5% | 89.2% | 75.1% | -1,285.6% | 33.8% | – | – |
| Diluted EPS 1Y growth | -33.3% | 25.0% | -200.0% | 100.0% | 100.0% | 102.6% | -457.1% | -600.0% | -150.0% | 90.0% | 82.6% | -1,050.0% | 50.0% | – | – |
| Operating cash flow 1Y growth | 13.4% | -14.2% | 8.2% | -79.6% | 960.7% | 114.0% | -730.1% | -264.8% | 991.6% | 49.6% | 13.7% | -4,173.2% | 91.6% | – | – |
| Operating cash flow 3Y CAGR | 1.7% | -42.6% | 32.8% | – | – | 24.2% | – | – | – | – | – | – | – | – | – |
| Operating cash flow 5Y CAGR | 17.9% | – | – | 32.9% | – | – | – | – | – | – | – | – | – | – | – |
| Free cash flow 1Y growth | 226.1% | 57.7% | -153.1% | -126.9% | 1,475.2% | 96.1% | -185.7% | 38.4% | -439.3% | – | – | – | – | – | – |
| CapEx 1Y growth | -90.2% | -40.6% | 65.8% | -32.1% | 281.3% | -51.5% | 8.3% | -57.5% | 523.5% | – | – | – | – | – | – |
| CapEx 3Y CAGR | -54.2% | -12.5% | 62.5% | 7.9% | 26.1% | -39.3% | 42.2% | – | 1,888.9% | – | – | – | – | – | – |
| CapEx 5Y CAGR | -24.3% | 4.3% | 17.7% | -10.4% | 39.7% | – | 415.1% | – | – | – | – | – | – | – | – |
| CapEx 10Y CAGR | – | 131.8% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Total assets 1Y growth | -2.1% | 5.5% | 28.9% | 23.5% | 61.2% | 24.2% | -25.8% | 157.6% | 276.1% | 130.3% | 125.0% | 0.00% | 1,256.2% | -35.9% | – |
| Total assets 3Y CAGR | 10.0% | 18.9% | 36.9% | 35.2% | 14.1% | 33.4% | 93.0% | 181.5% | 169.1% | 73.1% | 212.5% | 105.6% | – | – | – |
| Total assets 5Y CAGR | 21.5% | 27.4% | 18.8% | 36.4% | 70.5% | 83.1% | 106.2% | 118.9% | 205.1% | 114.2% | – | – | – | – | – |
| Total assets 10Y CAGR | 49.2% | 62.1% | 61.2% | 104.0% | 91.1% | – | – | – | – | – | – | – | – | – | – |
| Total equity 1Y growth | – | – | – | – | – | – | – | 461.1% | 2,096.1% | 71.5% | -0.19% | -90.4% | -97.1% | -223.8% | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.